The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I pharmacokinetics trial comparing PF-05280014 (a potential biosimilar) and trastuzumab in healthy volunteers (REFLECTIONS B327-01).
Donghua Yin
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer (I); Pfizer
Kerry B Barker
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Ruifeng Li
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Xu Meng
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Steven D Reich
Employment or Leadership Position - Atrium Staffing
Alejandro D Ricart
Stock Ownership - Pfizer
Dan Rudin
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Carrie T Taylor
Employment or Leadership Position - Atrium Staffing
Consultant or Advisory Role - Pfizer
Stock Ownership - Pfizer (I)
Charles M. Zacharchuk
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Arne G Hansson
Stock Ownership - Pfizer